about
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.Prevalence of primary immune thrombocytopenia in Oklahoma.Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.Prevalence of Weight Concerns and Obesity Among Smokers Calling a Quitline.Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.Trends in lung cancer incidence rates, Oklahoma 2005-2010.Concurrent use of cigarettes and smokeless tobacco among US males and femalesA gene-family analysis of 61 genetic variants in the nicotinic acetylcholine receptor genes for insulin resistance and type 2 diabetes in American Indians.Oklahoma Tobacco Helpline utilization and cessation among American Indians.E-Cigarettes for Immediate Smoking Substitution in Women Diagnosed with Cervical Dysplasia and Associated Disorders.A review of the validity and reliability of smokeless tobacco dependence measures.Community-Based Study Recruitment of American Indian Cigarette Smokers and Electronic Cigarette Users.Psychometric Properties of Fagerström Test for Nicotine Dependence for Smokeless Tobacco Users (FTND-ST).Electronic nicotine delivery system landscape in licensed tobacco retailers: results of a county-level survey in Oklahoma.Evaluating the role of smokeless tobacco use indices as brief measures of dependence.Long-term Quit Rates in Fax-Referred as Compared to Self-Referred Tobacco Quitline Registrants.Lifestyle behaviors among US cancer survivors.Assessment of the Tobacco Dependence Screener Among Smokeless Tobacco Users.Excise tax differences at Oklahoma smoke shops: an opportunity for inter-tribal coordination.Communities of excellence in tobacco control: changes in local policy and key outcomes.Does participation in a nurse visitation programme reduce the frequency of adverse perinatal outcomes in first-time mothers?All Nations Breath of Life: A Randomized Trial of Smoking Cessation for American Indians.Longitudinal evaluation of the Tobacco Stops With Me campaign.Increased evidence-based tobacco treatment through Oklahoma hospital system changes.Post-cessation weight concerns among women calling a state tobacco quitline.Tobacco control and prevention in Oklahoma: best practices in a preemptive state.Predictors of smokeless tobacco cessation among telephone quitline participants.Economics of tobacco control in Pakistan: estimating elasticities of cigarette demand.Building capacity to address tobacco-related disparities among American Indian and Hispanic/Latino communities: conceptual and systemic considerations.Addressing weight gain in smoking cessation treatment: a randomized controlled trial.E-cigarette use among treatment-seeking smokers: Moderation of abstinence by use frequency.Electronic nicotine delivery system (ENDS) use during smoking cessation: a qualitative study of 40 Oklahoma quitline callers.Trust in Health Information Sources: Survey Analysis of Variation by Sociodemographic and Tobacco Use Status in Oklahoma.A multiple motive/multi-dimensional approach to measure smokeless tobacco dependence.Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndromeDeterminants of salivary cotinine concentrations among smokeless tobacco usersReferral of patients with thrombocytopenia from primary care clinicians to hematologistsSupport for Local Tobacco Policy in a Preemptive StateReplicating state Quitline innovations to increase reach: findings from three states
P50
Q33388124-02B128EF-9CA6-41E2-8370-2CE49FDD4B04Q33401671-9B1D1056-F876-4CD9-883E-2A85F90A9DD3Q33401893-A1428410-4593-4077-8BEF-29242E979030Q33907976-1BC6519B-C7F7-4FDE-9732-A316BF2613C1Q35052794-B39CAFAF-94A9-4192-B40D-462474F98FBFQ35526034-82C2A6D1-B1D1-4E6E-A51A-DCDE3F67D231Q35994184-864BEF9C-FC4D-4A93-A048-D28519700B7BQ36047505-5A11D40D-B50E-473F-A176-F517BF147DD7Q36567211-7902772C-9B82-4577-8587-CB3E11D09C1EQ36732395-DF55179A-B3DC-426F-80B9-1491FEF2DEFFQ37975737-5213CBD2-DB32-40B9-BF62-C8D07F637753Q38688698-375261BF-7140-40D1-A436-2D724A85D566Q38848088-F366C8C5-8E4A-48F1-9D66-1B9432791587Q38857719-3F88BE2A-2705-41C4-AEF2-2E4B5C5D2010Q38953844-5B60495A-092B-4F2E-AC0B-1D491291DB63Q39091204-2B16FF5E-8CF1-4A81-8CDB-4F6E93F557DAQ40049891-01F54B6A-8285-4BA3-A2A6-FC2282BE84D4Q40157065-6A06D0B9-2AFE-4CED-8FD6-8263B642BB85Q40245136-5FF3A361-38EE-46E2-A07C-D6F9D6DA41F4Q40245139-AFC20707-EE12-4C7E-8199-90104916F696Q40426983-43F847DE-6E61-4A64-8681-CDE3E8CDE8B2Q40642445-023903F7-859E-48FF-8E8E-4F2C1A743AA7Q41663576-E8875BD3-8EE4-44E3-B274-EC7517D8AE02Q41663579-E219887C-81DD-4F09-AFDA-07B7948AD1B5Q41663588-B7B549F9-D41A-43C6-A290-CEFE65EF2635Q41663596-987F0D7C-1D00-4FA4-B368-CDAD1712B7D7Q41663605-C8C49D5C-C87E-4131-AD3E-556EB238DD8EQ43629177-51DD291C-1EB7-4D46-B9D3-C4A85B38B3ACQ45949893-F443D681-9A75-46EA-B5D1-64B33106D7C4Q47274929-B31A4A16-40EC-4BD3-98C2-3F43E0968BFAQ47834657-FA2800EA-1F8A-4829-B3DE-7468F2AC57B7Q48339368-161CBC94-803C-4F70-B371-19C33C868772Q50056368-8337FB5F-503C-4D17-96B9-62E1D38D8163Q54448369-8318FD7B-A39F-4206-8E3B-AFE69A417DD2Q81644184-6FCE5AB2-A4B7-4CB4-87C4-9945C4544FC3Q83017523-0DE62F29-1CA1-40CD-A469-3396226FFB54Q83713251-572FA383-350B-4354-9D2C-0DFABF98961CQ90230644-63AD2BF5-2A8D-4CE7-ADBA-8255B550CA8AQ92450574-C5C4B1D4-DEA4-4E54-9953-6AF837BAAD27
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laura A Beebe
@nl
Laura A Beebe
@sl
Laura A. Beebe
@en
Laura A. Beebe
@es
type
label
Laura A Beebe
@nl
Laura A Beebe
@sl
Laura A. Beebe
@en
Laura A. Beebe
@es
prefLabel
Laura A Beebe
@nl
Laura A Beebe
@sl
Laura A. Beebe
@en
Laura A. Beebe
@es
P106
P1153
7004477219
P21
P31
P496
0000-0002-5784-9203